WallStreetZenWallStreetZen

NASDAQ: OMGA
Omega Therapeutics Inc Stock

$1.79-0.05 (-2.72%)
Updated Jul 19, 2024
OMGA Price
$1.79
Fair Value Price
N/A
Market Cap
$98.73M
52 Week Low
$1.30
52 Week High
$6.30
P/E
-1.08x
P/B
2.39x
P/S
40.76x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.94M
Earnings
-$92.28M
Gross Margin
100%
Operating Margin
-1,854.55%
Profit Margin
-1,868.4%
Debt to Equity
3.44
Operating Cash Flow
-$75M
Beta
1.74
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

OMGA Overview

Omega Therapeutics, Inc. is developing a new class of programmable epigenetic medicines known as Omega Epigenomic Controllers. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth, and differentiation to cell death. It has deciphered the three-dimensional architecture of the human genome and its accompanying regulators, which are organized into distinct and evolutionarily conserved structures called Insulated Genomic Domains. Omega Therapeutics was incorporated in 2016 and is headquartered in Cambridge, MA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OMGA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OMGA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OMGA is good value based on its book value relative to its share price (2.39x), compared to the US Biotechnology industry average (6.22x)
P/B vs Industry Valuation
OMGA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OMGA due diligence checks available for Premium users.

Be the first to know about important OMGA news, forecast changes, insider trades & much more!

OMGA News

Valuation

OMGA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.08x
Industry
-18.27x
Market
29.62x

OMGA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.39x
Industry
6.22x
OMGA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

OMGA's financial health

Profit margin

Revenue
$2.4M
Net Income
-$20.1M
Profit Margin
-852.9%
OMGA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OMGA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$183.7M
Liabilities
$142.3M
Debt to equity
3.44
OMGA's short-term assets ($70.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OMGA's long-term liabilities ($117.65M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OMGA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.8M
Investing
$4.5M
Financing
-$1.1M
OMGA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OMGA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
OMGA$98.73M-2.72%-1.08x2.39x
SGMT$98.61M-4.04%-0.08x0.52x
VTGN$98.91M-1.08%-2.41x0.87x
CRDF$100.63M-4.66%-2.50x1.65x
ACET$101.90M+0.81%-0.42x0.39x

Omega Therapeutics Stock FAQ

What is Omega Therapeutics's quote symbol?

(NASDAQ: OMGA) Omega Therapeutics trades on the NASDAQ under the ticker symbol OMGA. Omega Therapeutics stock quotes can also be displayed as NASDAQ: OMGA.

If you're new to stock investing, here's how to buy Omega Therapeutics stock.

What is the 52 week high and low for Omega Therapeutics (NASDAQ: OMGA)?

(NASDAQ: OMGA) Omega Therapeutics's 52-week high was $6.30, and its 52-week low was $1.30. It is currently -71.59% from its 52-week high and 37.69% from its 52-week low.

How much is Omega Therapeutics stock worth today?

(NASDAQ: OMGA) Omega Therapeutics currently has 55,154,985 outstanding shares. With Omega Therapeutics stock trading at $1.79 per share, the total value of Omega Therapeutics stock (market capitalization) is $98.73M.

Omega Therapeutics stock was originally listed at a price of $16.00 in Jul 30, 2021. If you had invested in Omega Therapeutics stock at $16.00, your return over the last 2 years would have been -88.81%, for an annualized return of -66.55% (not including any dividends or dividend reinvestments).

How much is Omega Therapeutics's stock price per share?

(NASDAQ: OMGA) Omega Therapeutics stock price per share is $1.79 today (as of Jul 19, 2024).

What is Omega Therapeutics's Market Cap?

(NASDAQ: OMGA) Omega Therapeutics's market cap is $98.73M, as of Jul 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Omega Therapeutics's market cap is calculated by multiplying OMGA's current stock price of $1.79 by OMGA's total outstanding shares of 55,154,985.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.